Skip to content

Clinical trials

Recruiting Breast Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Recruiting Country / region: Australia Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
20202
20213
20227
202314
202410
202524
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting71

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
AstraZeneca4
Novartis Pharmaceuticals4
BeOne Medicines3
Merck Sharp & Dohme LLC3
BioNTech SE2
Bristol-Myers Squibb2
Daiichi Sankyo2
Eli Lilly and Company2
Olema Pharmaceuticals, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms71
Carcinoma, Non-Small-Cell Lung15
Ovarian Neoplasms14
Endometrial Neoplasms13
Pancreatic Neoplasms13
Neoplasm Metastasis12
Prostatic Neoplasms11
Colorectal Neoplasms10
Stomach Neoplasms10
Triple Negative Breast Neoplasms10

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.